Literature DB >> 26143477

Liquid chromatography-mass spectrometry analysis of five bisphosphonates in equine urine and plasma.

April S Y Wong1, Emmie N M Ho2, Terence S M Wan3, Kenneth K H Lam4, Brian D Stewart4.   

Abstract

Bisphosphonates are used in the management of skeletal disorder in humans and horses, with tiludronic acid being the first licensed veterinary medicine in the treatment of lameness associated with degenerative joint disease. Bisphosphonates are prohibited in horseracing according to Article 6 of the International Agreement on Breeding, Racing and Wagering (published by the International Federation of Horseracing Authorities). In order to control the use of bisphosphonates in equine sports, an effective method to detect the use of bisphosphonates is required. Bisphosphonates are difficult-to-detect drugs due to their hydrophilic properties. The complexity of equine matrices also added to their extraction difficulties. This study describes a method for the simultaneous detection of five bisphosphonates, namely alendronic acid, clodronic acid, ibandronic acid, risedronic acid and tiludronic acid, in equine urine and plasma. Bisphosphonates were first isolated from the sample matrices by solid-phase extractions, followed by methylation with trimethylsilyldiazomethane prior to liquid chromatography - tandem mass spectrometry analysis using selective reaction monitoring in the positive electrospray ionization mode. The five bisphosphonates could be detected at low ppb levels in 0.5mL equine plasma or urine with acceptable precision, fast instrumental turnaround time, and negligible matrix interferences. The method has also been applied to the excretion study of tiludronic acid in plasma and urine collected from a horse having been administered a single dose of tiludronic acid. The applicability and effectiveness of the method was demonstrated by the successful detection and confirmation of the presence of tiludronic acid in an overseas equine urine sample. To our knowledge, this is the first reported method in the successful screening and confirmation of five amino- and non-amino bisphosphonates in equine biological samples.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amino bisphosphonates; Doping control analysis; Horse; Liquid chromatography–mass spectrometry; Non-amino bisphosphonates; Plasma; Tiludronic acid; Urine

Mesh:

Substances:

Year:  2015        PMID: 26143477     DOI: 10.1016/j.jchromb.2015.06.020

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Quantitative determination of a potent geranylgeranyl diphosphate synthase inhibitor using LC-MS/MS: Derivatization and application.

Authors:  Yashpal S Chhonker; Staci L Haney; Robert A Matthiesen; David F Wiemer; Sarah A Holstein; Daryl J Murry
Journal:  J Pharm Biomed Anal       Date:  2018-02-06       Impact factor: 3.935

Review 2.  Is the Use of Bisphosphonates Putting Horses at Risk? An Osteoclast Perspective.

Authors:  Fernando B Vergara-Hernandez; Brian D Nielsen; Aimee C Colbath
Journal:  Animals (Basel)       Date:  2022-07-03       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.